Sofia Järnum

1.2k total citations
37 papers, 599 citations indexed

About

Sofia Järnum is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Sofia Järnum has authored 37 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Genetics. Recurrent topics in Sofia Järnum's work include Immunodeficiency and Autoimmune Disorders (4 papers), Blood groups and transfusion (4 papers) and Clinical Nutrition and Gastroenterology (3 papers). Sofia Järnum is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (4 papers), Blood groups and transfusion (4 papers) and Clinical Nutrition and Gastroenterology (3 papers). Sofia Järnum collaborates with scholars based in Sweden, Denmark and United States. Sofia Järnum's co-authors include Christian Kjellman, Lena Winstedt, Robert Bockermann, Anna Runström, Lars Björck, E Gudmand-Høyer, Pierre Åman, Michael Schwartz, Johan Malmström and Christofer Karlsson and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Gut.

In The Last Decade

Sofia Järnum

36 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Järnum Sweden 13 152 118 112 94 91 37 599
E. S. Curtoni Italy 14 87 0.6× 65 0.6× 121 1.1× 209 2.2× 25 0.3× 37 639
Jan A. Bruijn Netherlands 10 162 1.1× 49 0.4× 121 1.1× 355 3.8× 33 0.4× 15 714
Jort S.J. Gerritsma Netherlands 13 141 0.9× 35 0.3× 117 1.0× 391 4.2× 96 1.1× 14 823
Thompson Ja United States 16 74 0.5× 43 0.4× 228 2.0× 228 2.4× 39 0.4× 36 673
Deeg Hj United States 15 97 0.6× 61 0.5× 85 0.8× 231 2.5× 89 1.0× 46 893
Hiroshi Nagaya United States 15 105 0.7× 36 0.3× 92 0.8× 118 1.3× 174 1.9× 47 762
David Maurer United States 16 205 1.3× 62 0.5× 212 1.9× 229 2.4× 45 0.5× 32 805
P Stammler Switzerland 12 114 0.8× 65 0.6× 91 0.8× 355 3.8× 139 1.5× 20 837
C. L. Pirani United States 13 135 0.9× 37 0.3× 37 0.3× 115 1.2× 81 0.9× 18 549
Anu Soots Finland 16 87 0.6× 30 0.3× 237 2.1× 238 2.5× 50 0.5× 43 690

Countries citing papers authored by Sofia Järnum

Since Specialization
Citations

This map shows the geographic impact of Sofia Järnum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Järnum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Järnum more than expected).

Fields of papers citing papers by Sofia Järnum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Järnum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Järnum. The network helps show where Sofia Järnum may publish in the future.

Co-authorship network of co-authors of Sofia Järnum

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Järnum. A scholar is included among the top collaborators of Sofia Järnum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Järnum. Sofia Järnum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bockermann, Robert, Sofia Järnum, Anna Runström, et al.. (2021). Imlifidase-generated Single-cleaved IgG: Implications for Transplantation. Transplantation. 106(7). 1485–1496. 12 indexed citations
2.
Lorant, Tomas, Mats Bengtsson, Torsten Eich, et al.. (2018). Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients. American Journal of Transplantation. 18(11). 2752–2762. 70 indexed citations
3.
Karlsson, Christofer, Sofia Järnum, Lena Winstedt, et al.. (2018). Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS. Molecular & Cellular Proteomics. 17(6). 1097–1111. 16 indexed citations
4.
Järnum, Sofia, Anna Runström, Robert Bockermann, et al.. (2017). Enzymatic Inactivation of Endogenous IgG by IdeS Enhances Therapeutic Antibody Efficacy. Molecular Cancer Therapeutics. 16(9). 1887–1897. 9 indexed citations
5.
Wang, Yuzhong, Ming Hu, Weifang Wang, et al.. (2017). IgG-degrading enzyme of Streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barré syndrome. Experimental Neurology. 291. 134–140. 18 indexed citations
6.
Winstedt, Lena, Sofia Järnum, Emma Andersson Nordahl, et al.. (2015). Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS – A Novel Therapeutic Opportunity. PLoS ONE. 10(7). e0132011–e0132011. 81 indexed citations
7.
Varas, Laura A., Lars Ohlsson, Gabriella Honeth, et al.. (2007). α 10 Integrin Expression Is Up-Regulated on Fibroblast Growth Factor-2-Treated Mesenchymal Stem Cells with Improved Chondrogenic Differentiation Potential. Stem Cells and Development. 16(6). 965–978. 76 indexed citations
8.
Willén, Helena, Carola Andersson, Marita Olsson, et al.. (2006). The Myxoid/Round Cell Liposarcoma Fusion Oncogene FUS-DDIT3 and the Normal DDIT3 Induce a Liposarcoma Phenotype in Transfected Human Fibrosarcoma Cells. American Journal Of Pathology. 168(5). 1642–1653. 67 indexed citations
9.
Järnum, Sofia, et al.. (2004). LEPREL1, a novel ER and Golgi resident member of the Leprecan family. Biochemical and Biophysical Research Communications. 317(2). 342–351. 28 indexed citations
10.
Kjellman, Christian, Gabriella Honeth, Sofia Järnum, et al.. (2004). Identification and characterization of a human smad3 splicing variant lacking part of the linker region. Gene. 327(2). 141–152. 9 indexed citations
11.
Ladefoged, K., Ove B. Schaffalitzky de Muckadell, & Sofia Järnum. (1987). Faecal Osmolality and Electrolyte Concentrations in Chronic Diarrhoea: Do They Provide Diagnostic Clues?. Scandinavian Journal of Gastroenterology. 22(7). 813–820. 14 indexed citations
12.
Axelsson, C. K. & Sofia Järnum. (1977). Elemental Diet in Gastrointestinal Diseases: Experience from a Case Material of 59 Patients. Transfusion Medicine and Hemotherapy. 4(6). 313–318. 1 indexed citations
13.
Danø, P, Sofia Järnum, & Nielsen Ov. (1973). Intestinal shunt-operation in obesity. A comparison of three types of operation.. PubMed. 8(5). 457–64. 16 indexed citations
14.
Gudmand-Høyer, E & Sofia Järnum. (1970). Incidence and clinical significance of lactose malabsorption in ulcerative colitis and Crohn's disease. Gut. 11(4). 338–343. 27 indexed citations
15.
Bendixen, G, et al.. (1968). Gastrointestinal Involvement in Systemic Scleroderma. Dermatology. 137(1). 26–35. 6 indexed citations
16.
Järnum, Sofia, et al.. (1967). Investigations on gastrointestinal protein loss in the nephrotic syndrome.. PubMed. 211–6. 1 indexed citations
17.
Järnum, Sofia, et al.. (1966). Pancreatic catabolism of albumin and gamma-globulin.. PubMed. 31(2). 223–30. 2 indexed citations
18.
Järnum, Sofia, et al.. (1961). Experimental plasma protein loss into the digestive tract in dogs.. PubMed. 121. 242–52. 4 indexed citations
19.
Lorenzen, I., Thomas G. Gabuzda, Sofia Järnum, & Marc Schwartz. (1960). [The use of Cr-51 labelled erythrocytes in hematological diagnosis].. PubMed. 122. 847–52. 2 indexed citations
20.
Anthonisen, P, et al.. (1958). Clinical experience with the Skeggs-Leonards type of artificial kidney.. PubMed. 13(24). 1503–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026